SCHEMBL29696509

SCHEMBL29696509

CN(C)CCOCCOC1CCC(N(Cc2ccccc2)Cc2ccccc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
USP2 O75604 1/20 0.42
TSHR P16473 3/20 0.41
KMT2A Q03164 2/20 0.40
YTHDC1 Q96MU7 1/20 0.40
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
ACHE P22303 1/20 0.38
LTA4H P09960 1/20 0.38
OPRM1 P35372 2/20 0.37
SLC6A3 Q01959 2/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7772148 0.92 KMT2A (0.43) TSHRKMT2AYTHDC1SLC6A2SLC6A4
SCHEMBL7772151 0.92 KMT2A (0.43) TSHRKMT2AYTHDC1SLC6A2SLC6A4
SCHEMBL18428792 0.85 YTHDC1 (0.40) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
SCHEMBL18428790 0.85 YTHDC1 (0.40) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
SCHEMBL18365044 0.85 YTHDC1 (0.40) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
SCHEMBL23329876 0.83 YTHDC1 (0.43) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
SCHEMBL5006779 0.83 YTHDC1 (0.43) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
SCHEMBL5009994 0.83 YTHDC1 (0.43) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
SCHEMBL29495252 0.83 YTHDC1 (0.42) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1
Hydrochloric Acid SCHEMBL21222660 0.82 YTHDC1 (0.42) KMT2AYTHDC1SLC6A2SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003980-A1 HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 Ribon Therapeutics Inc. (US) 2022-06-01 EP disclosed